Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

Endocrine-related Cancer
J HadouxE Baudin

Abstract

There is no standard for second-line chemotherapy in poorly differentiated grade 3 neuroendocrine carcinoma (G3-NEC) patients. We analyzed the antitumor efficacy of 5-fluorouracil and oxaliplatin (FOLFOX) chemotherapy in this population. A single-center retrospective analysis of consecutive G3-NEC patients treated with FOLFOX chemotherapy after failure of a cisplatinum-based regimen between December 2003 and June 2012 was performed. Progression-free survival (PFS), overall survival (OS), response rate, and safety were assessed according to RECIST 1.1 and NCI.CTC v4 criteria. Twenty consecutive patients were included (seven males and 13 females; median age 55; range 23-87 years) with a performance status of 0-1 in 75% of them. Primary location was gastroenteropancreatic in 12, thoracic in four, other in two, and unknown in two patients. There were 12 (65%) large-cell and 7 (30%) small-cell G3-NEC tumors, and 1 (5%) unknown. All patients had distant metastases. Twelve (60%) patients received FOLFOX as second-line treatment and 8 (40%) as third-line treatment or later and the median number of administered cycles was 6 (range 3-14). The median follow-up was 19 months. Median PFS was 4.5 months. Among the 17 evaluable patients, five...Continue Reading

References

Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Sep 29, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C MascauxUNKNOWN European Lung Cancer Working Party (ELCWP)
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Oct 11, 2005·The Journal of Thoracic and Cardiovascular Surgery·Eric LimPeter Goldstraw
Dec 31, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hisao AsamuraKanji Nagai
Feb 23, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Eric Baudin
Mar 27, 2007·Cancer Treatment Reviews·Britta StordalRoss Davey
Apr 4, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TheodoreA Flechon
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoDouglas B Evans
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 23, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Aldo ScarpaMassimo Falconi
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SørensenUNKNOWN ESMO Guidelines Working Group
Feb 18, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Natsuko Tsuda OkitaKuniaki Shirao
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PanzutoMassimo Falconi
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan R StrosbergLarry K Kvols
Jul 13, 2013·Endocrine-related Cancer·Fritz-Line Vélayoudom-CéphiseEric Baudin
Apr 29, 2014·Cancer·Halfdan SorbyeJames C Yao

❮ Previous
Next ❯

Citations

Nov 29, 2015·Hematology/oncology Clinics of North America·Jennifer R Eads
Jun 27, 2015·Endocrine-related Cancer·M HeetfeldUNKNOWN other Knowledge Network members
Feb 6, 2017·Digestion·Anja Rinke, Thomas M Gress
Jul 15, 2017·Expert Opinion on Drug Safety·A FaggianoA Colao
Sep 12, 2017·Reviews in Endocrine & Metabolic Disorders·Anna AngelousiAshley Grossman
Dec 13, 2018·Endocrine-related Cancer·Esben Andreas CarlsenHalfdan Sorbye
Jan 13, 2019·The Oncologist·Katharine E H ThomasRobert A Ramirez
Jun 9, 2020·Luminescence : the Journal of Biological and Chemical Luminescence·Shyamal BaruahAmrit Puzari
Jun 5, 2020·Journal of Clinical Medicine·Anna Pellat, Romain Coriat
Jun 6, 2017·International Cancer Conference Journal·Noriyuki TagaiKanji Katayama
Oct 30, 2019·World Journal of Gastroenterology : WJG·Melissa FrizzieroMairéad G McNamara
Sep 4, 2020·World Journal of Gastrointestinal Oncology·Monjur Ahmed
Sep 29, 2020·World Journal of Gastroenterology : WJG·Rani KanthanSelliah C Kanthan
Aug 21, 2019·Current Treatment Options in Oncology·Mohamad Bassam Sonbol, Thorvardur R Halfdanarson
Apr 14, 2020·Pancreas·Patrick W McGarrahThorvardur R Halfdanarson
Aug 31, 2020·World Journal of Gastrointestinal Oncology·Ming-Yi ZhangShuang Zhang
Jun 19, 2020·Journal of Clinical Medicine·Lola-Jade PalmieriRomain Coriat
Dec 19, 2020·Expert Opinion on Drug Safety·Apostolos Koffas, Christos Toumpanakis
Jan 13, 2021·Medicine·Burcin ÖzdirikBertram Wiedenmann
Dec 29, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Víctor Rodriguez-FreixinosSimron Singh
Jan 27, 2021·The Oncologist·Alex J LiuMohamad Bassam Sonbol
Dec 17, 2019·Trends in Endocrinology and Metabolism : TEM·Krystallenia I AlexandrakiGregory A Kaltsas
May 20, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R B GallebergH Sorbye
Apr 13, 2021·Reviews in Endocrine & Metabolic Disorders·Paula Espinosa-OlarteRocio Garcia-Carbonero
May 12, 2021·Current Opinion in Oncology·Christiane Jungels, Amélie Deleporte
Jun 11, 2021·Current Treatment Options in Oncology·Kazhan MollazadeganJoakim Crona
May 18, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Julien HadouxRomain Desgrippes
Jul 14, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kian-Huat LimAndrea Wang-Gillam
Aug 3, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Manisha H ShahCindy Hochstetler
Aug 4, 2021·Journal of Neuroendocrinology·Jain PranteshAmr Mohamed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
S P DobbsE M Bessell
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Marcos G JoppertLina Asmar
© 2021 Meta ULC. All rights reserved